Reinhard Dummer
ZHAW Zurich University of Applied Sciences(CH)University of Zurich(CH)University Hospital of Zurich(CH)Kantonsspital Aarau(CH)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Cutaneous Melanoma Detection and Management, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses
Most-Cited Works
- → Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma(2015)8,054 cited
- → Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation(2011)7,653 cited
- → Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma(2017)5,337 cited
- → Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma(2019)3,640 cited
- → Genomic correlates of response to CTLA-4 blockade in metastatic melanoma(2015)2,936 cited
- → Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells(1998)2,862 cited